Universkin SAS / Croma-Pharma GmbH
Exclusive Financial Advisor to Universkin for the completion of a strategic distribution agreement with Croma-Pharma GmbH and divestiture of a 5% stake to Croma.
Advised the French personalized dermocosmetics company Universkin SAS, in their exclusive partnering alliance with Vienna, Austria-based family-owned Medical Aesthetics Group Croma Pharmaceuticals GmbH for Western European Countries except France, Russia, as well as USA and Canada. The consideration included an upfront payment of € 5m for a minority equity stake in Universkin as well as, regulatory and financial performance-based milestones features and a progressive staggered Royalty Scale proportional to the achieved Universkin product sales.
.